Lab
University Hospitals Laboratory Services Foundation
University Hospitals Laboratory Services Foundation was paid $58K by Medicaid between Jan 2018 and Apr 2022, across 45 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 21% of everything it billed.
33Billing provider infoUNIVERSITY HOSPITALS LABORATORY SERVICES FOUNDATION
CLEVELAND, OH 44106
CLEVELAND, OH 44106
33aNPI1578706438assigned 04/08/2009
33bProvider typeClinical Medical Laboratory
28Total paid$58K
24GClaims26,308
24DCodes billed45
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Ohio
Rank by total paid#76 of 116
Median peer was paid$313K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,536 | $7K | |
| 2019 | 6,393 | $12K | |
| 2020 | 10,464 | $26K | |
| 2021 | 4,902 | $13K | |
| 2022 | 13 | $4.50 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 21% | 713 | 642 | $12K |
| 80197 | 8.3% | 1,672 | 637 | $5K | |
| 80053 | Comprehensive metabolic panel | 7.1% | 2,049 | 1,908 | $4K |
| 36415 | Collection of venous blood by venipuncture | 6.5% | 6,106 | 4,382 | $4K |
| 80069 | 6.1% | 2,199 | 1,012 | $4K | |
| 80061 | Lipid panel | 5.7% | 1,399 | 1,351 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.6% | 2,254 | 1,795 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.1% | 732 | 707 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.8% | 226 | 207 | $3K |
| 87799 | 4.5% | 338 | 202 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4.5% | 1,112 | 1,085 | $3K |
| 85027 | 4.5% | 2,509 | 1,526 | $3K |
33 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 3.0% | 1,216 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.1% | 247 | $1K |
| 80050 | General health panel | 1.4% | 96 | $796.55 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 550 | $765.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 385 | $683.53 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.2% | 45 | $668.86 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 67 | $588.94 |
| 83735 | <1% | 609 | $537.82 | |
| 82570 | <1% | 466 | $417.54 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $329.44 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $329.44 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 16 | $320.00 |
| 82607 | <1% | 74 | $213.65 | |
| 81001 | <1% | 265 | $159.54 | |
| 87077 | <1% | 70 | $127.30 | |
| 84156 | <1% | 197 | $109.95 | |
| 84439 | <1% | 53 | $95.59 | |
| 85610 | <1% | 198 | $90.34 | |
| 87186 | <1% | 38 | $68.48 | |
| 80076 | <1% | 44 | $68.07 | |
| 82728 | <1% | 28 | $57.33 | |
| 84153 | <1% | 12 | $55.20 | |
| 80346 | <1% | 12 | $53.16 | |
| 80361 | <1% | 12 | $53.16 | |
| 83540 | <1% | 45 | $37.39 | |
| 83550 | <1% | 26 | $31.46 | |
| 82043 | <1% | 25 | $28.55 | |
| 87340 | <1% | 33 | $24.57 | |
| 85652 | <1% | 37 | $21.11 | |
| 86704 | <1% | 36 | $13.22 | |
| 81003 | <1% | 26 | $9.45 | |
| 86706 | <1% | 17 | $8.87 | |
| 85730 | <1% | 30 | $1.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Parent organizationUNIVERSITY HOSPITALS LABORATORY SERVICES FOUNDATION
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.